124 related articles for article (PubMed ID: 38676439)
1. Associations between pathological features and risk of metachronous colorectal cancer.
Zhang Y; Win AK; Makalic E; Buchanan DD; Pai RK; Phipps AI; Rosty C; Boussioutas A; Karahalios A; Jenkins MA
Int J Cancer; 2024 Apr; ():. PubMed ID: 38676439
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study.
Jayasekara H; Reece JC; Buchanan DD; Rosty C; Dashti SG; Ait Ouakrim D; Winship IM; Macrae FA; Boussioutas A; Giles GG; Ahnen DJ; Lowery J; Casey G; Haile RW; Gallinger S; Le Marchand L; Newcomb PA; Lindor NM; Hopper JL; Parry S; Jenkins MA; Win AK
Int J Cancer; 2016 Sep; 139(5):1081-90. PubMed ID: 27098183
[TBL] [Abstract][Full Text] [Related]
3. Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives.
Win AK; Buchanan DD; Rosty C; MacInnis RJ; Dowty JG; Dite GS; Giles GG; Southey MC; Young JP; Clendenning M; Walsh MD; Walters RJ; Boussioutas A; Smyrk TC; Thibodeau SN; Baron JA; Potter JD; Newcomb PA; Le Marchand L; Haile RW; Gallinger S; Lindor NM; Hopper JL; Ahnen DJ; Jenkins MA
Gut; 2015 Jan; 64(1):101-10. PubMed ID: 24615377
[TBL] [Abstract][Full Text] [Related]
4. Risk of Metachronous Colorectal Neoplasm after a Segmental Colectomy in Lynch Syndrome Patients According to Mismatch Repair Gene Status.
Quezada-Diaz FF; Hameed I; von Mueffling A; Salo-Mullen EE; Catalano A; Smith JJ; Weiser MR; Garcia-Aguilar J; Stadler ZK; Guillem JG
J Am Coll Surg; 2020 Apr; 230(4):669-675. PubMed ID: 32007537
[TBL] [Abstract][Full Text] [Related]
5. Altered DNA mismatch repair expression in synchronous and metachronous colorectal cancers.
Aslanian HR; Burgart LJ; Harrington JJ; Mahoney DW; Zinsmeister AR; Thibodeau SN; Ahlquist DA
Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1385-8. PubMed ID: 18639494
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah.
Samadder NJ; Curtin K; Wong J; Tuohy TM; Mineau GP; Smith KR; Pimentel R; Pappas L; Boucher K; Garrido-Laguna I; Provenzale D; Burt RW
Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2078-84.e1-2. PubMed ID: 24768809
[TBL] [Abstract][Full Text] [Related]
7. Tumor size is an independent risk predictor for metachronous colorectal cancer.
Kato T; Alonso S; Muto Y; Perucho M; Rikiyama T
Oncotarget; 2016 Apr; 7(14):17896-904. PubMed ID: 26910116
[TBL] [Abstract][Full Text] [Related]
8. Aberrant Partial Chromosomal Instability With Chemotherapeutically Resistant Metachronous Colorectal Cancer Following a Synchronous Primary Colorectal Cancer: A Case Report.
Dominic JL; Feroz SH; Muralidharan A; Ahmed A; Thirunavukarasu P
Cureus; 2020 Nov; 12(11):e11308. PubMed ID: 33282585
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for metachronous colorectal cancer and advanced neoplasia following primary colorectal cancer: a systematic review and meta-analysis.
Zhang Y; Karahalios A; Aung YK; Win AK; Boussioutas A; Jenkins MA
BMC Gastroenterol; 2023 Nov; 23(1):421. PubMed ID: 38036994
[TBL] [Abstract][Full Text] [Related]
10. Metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after extensive versus partial colectomy in the Netherlands: a retrospective cohort study.
Eikenboom EL; Moen S; van Leerdam ME; Papageorgiou G; Doukas M; Tanis PJ; Dekker E; Wagner A; Spaander MCW;
Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1106-1117. PubMed ID: 37865103
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.
Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
Lancet Gastroenterol Hepatol; 2020 May; 5(5):475-484. PubMed ID: 32066530
[TBL] [Abstract][Full Text] [Related]
12. Synchronous/metachronous endometrial and colorectal malignancies in Taiwanese women: a population-based nationwide study.
Chao A; Wu RC; Chao AS; Chang WY; Wu CH; Lai CH; Yang LY
Arch Gynecol Obstet; 2022 Jul; 306(1):165-172. PubMed ID: 35001183
[TBL] [Abstract][Full Text] [Related]
13. Survival Outcome and Risk of Metachronous Colorectal Cancer After Surgery in Lynch Syndrome.
Kim TJ; Kim ER; Hong SN; Kim YH; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Kim K; Kim K; Chang DK
Ann Surg Oncol; 2017 Apr; 24(4):1085-1092. PubMed ID: 27766559
[TBL] [Abstract][Full Text] [Related]
14. Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers.
Win AK; Parry S; Parry B; Kalady MF; Macrae FA; Ahnen DJ; Young GP; Lipton L; Winship I; Boussioutas A; Young JP; Buchanan DD; Arnold J; Le Marchand L; Newcomb PA; Haile RW; Lindor NM; Gallinger S; Hopper JL; Jenkins MA
Ann Surg Oncol; 2013 Jun; 20(6):1829-36. PubMed ID: 23358792
[TBL] [Abstract][Full Text] [Related]
15. The impact of an open or laparoscopic approach on the development of metachronous peritoneal metastases after primary resection of colorectal cancer: results from a population-based cohort study.
Lurvink RJ; Rijken A; Bakkers C; Lemmens VE; de Reuver PR; Tuynman JB; Kok NF; Nienhuijs SW; van Erning FN; de Hingh IHJT
Surg Endosc; 2022 Sep; 36(9):6551-6557. PubMed ID: 35059835
[TBL] [Abstract][Full Text] [Related]
16. Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome.
Chau R; Dashti SG; Ait Ouakrim D; Buchanan DD; Clendenning M; Rosty C; Winship IM; Young JP; Giles GG; Macrae FA; Boussioutas A; Parry S; Figueiredo JC; Levine AJ; Ahnen DJ; Casey G; Haile RW; Gallinger S; Le Marchand L; Thibodeau SN; Lindor NM; Newcomb PA; Potter JD; Baron JA; Hopper JL; Jenkins MA; Win AK
Int J Epidemiol; 2016 Jun; 45(3):940-53. PubMed ID: 27063605
[TBL] [Abstract][Full Text] [Related]
17. Association between family history of colorectal cancer and the risk of metachronous colorectal neoplasia following polypectomy in patients aged < 50 years.
Kim NH; Jung YS; Park JH; Park DI; Sohn CI
J Gastroenterol Hepatol; 2019 Feb; 34(2):383-389. PubMed ID: 30554426
[TBL] [Abstract][Full Text] [Related]
18. Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study.
Lurvink RJ; Bakkers C; Rijken A; van Erning FN; Nienhuijs SW; Burger JW; Creemers GJ; Verhoef C; Lemmens VE; De Hingh IH
Eur J Surg Oncol; 2021 May; 47(5):1026-1033. PubMed ID: 33272737
[TBL] [Abstract][Full Text] [Related]
19. Synchronous polyps predict metachronous colorectal lesions after curative resection of colorectal cancer.
Pozza A; Ruffolo C; Fiorot A; Padoan L; Erroi F; Massani M; Caratozzolo E; Bonariol L; Ferrara F; Norberto L; Castoro C; Bassi N; Scarpa M
Acta Chir Belg; 2016 Aug; 116(4):225-230. PubMed ID: 27426670
[TBL] [Abstract][Full Text] [Related]
20. Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma.
Obermair A; Youlden DR; Young JP; Lindor NM; Baron JA; Newcomb P; Parry S; Hopper JL; Haile R; Jenkins MA
Int J Cancer; 2010 Dec; 127(11):2678-84. PubMed ID: 20533284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
